Setting analytical performance specifications for copeptin-based testing
Kay Weng Choy,Karthik Nediyedath,Ian Farrance,Tze Ping Loh
DOI: https://doi.org/10.1515/cclm-2024-0626
2024-06-13
Clinical Chemistry and Laboratory Medicine (CCLM)
Abstract:Funding source: RCPA Foundation Research ethics: Not applicable. Informed consent: Not applicable. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission. Competing interests: The authors state no competing interests. Research funding: This manuscript was supported by a Royal College of Pathologists of Australasia (RCPA) Foundation RCPA Quality Assurance Programs Research Grant awarded to Dr. Choy. Data availability: Not applicable. 1. Refardt, J, Atila, C, Christ-Crain, M. New insights on diagnosis and treatment of AVP deficiency. Rev Endocr Metab Disord 2023. https://doi.org/10.1007/s11154-023-09862-w. 10.1007/s11154-023-09862-wSearch in Google Scholar PubMed PubMed Central 2. Refardt, J, Atila, C, Chifu, I, Ferrante, E, Erlic, Z, Drummond, JB, et al.. Arginine or hypertonic saline-stimulated copeptin to diagnose AVP deficiency. N Engl J Med 2023;389:1877–87. https://doi.org/10.1056/nejmoa2306263. Search in Google Scholar PubMed 3. Tuli, G, Tessaris, D, Einaudi, S, Matarazzo, P, De Sanctis, L. Copeptin role in polyuria-polydipsia syndrome differential diagnosis and reference range in paediatric age. Clin Endocrinol 2018;88:873–9. https://doi.org/10.1111/cen.13583. Search in Google Scholar PubMed 4. Loh, TP, Smith, AF, Bell, KJL, Lord, SJ, Ceriotti, F, Jones, G, et al.. Setting analytical performance specifications using HbA1c as a model measurand. Clin Chim Acta 2021;523:407–14. https://doi.org/10.1016/j.cca.2021.10.016. Search in Google Scholar PubMed 5. Sandberg, S, Fraser, CG, Horvath, AR, Jansen, R, Jones, G, Oosterhuis, W, et al.. Defining analytical performance specifications: Consensus statement from the 1st strategic conference of the European federation of clinical chemistry and laboratory medicine. Clin Chem Lab Med 2015;53:833–5. https://doi.org/10.1515/cclm-2015-0067. Search in Google Scholar PubMed 6. Kilpatrick, ES, Butler, AE, Atkin, SL, Sacks, DB. Establishing pragmatic analytical performance specifications for blood beta-hydroxybutyrate testing. Clin Chem 2023;69:519–24. https://doi.org/10.1093/clinchem/hvad020. Search in Google Scholar PubMed 7. Choy, KW, Carobene, A, Loh, TP, Chiang, C, Wijeratne, N, Locatelli, M, et al.. Biological variation estimates for plasma copeptin and clinical implications. J Appl Lab Med 2024;9:430–9. https://doi.org/10.1093/jalm/jfae005. Search in Google Scholar PubMed 8. Guldhaug, NA, Røys, E, Viste, K, Thorsby, PM, Sylte, MS, Torsvik, J, et al.. Week-to-week within-subject and between-subject biological variation of copeptin. Clin Chem Lab Med 2023;62:e29–33. https://doi.org/10.1515/cclm-2023-0673. Search in Google Scholar PubMed PubMed Central 9. Thermo Fisher Scientific . BRAHMS Copeptin ProAVP KRYPTOR: instruction for use. Version R03en . MA, USA: Thermo Fisher Scientific; 2019. Search in Google Scholar 10. Bolignano, D, Cabassi, A, Fiaccadori, E, Ghigo, E, Pasquali, R, Peracino, A, et al.. Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clin Chem Lab Med 2014;52:1447–56. https://doi.org/10.1515/cclm-2014-0379. Search in Google Scholar PubMed 11. Ristagno, G, Latini, R, Plebani, M, Zaninotto, M, Vaahersalo, J, Masson, S, et al.. Copeptin levels are associated with organ dysfunction and death in the intensive care unit after out-of-hospita -Abstract Truncated-
medical laboratory technology